Literature DB >> 28557595

Chondroblastoma: An Update.

Wenqian Chen, Lisa M DiFrancesco1.   

Abstract

Chondroblastoma is a rare primary bone tumor of young people that typically arises in the ends of the long bones. Radiologic investigations show a small, circumscribed, lytic lesion. The tumor is characterized histologically by the proliferation of chondroblasts along with areas of mature cartilage, giant cells, and occasionally, secondary aneurysmal bone cyst formation. Chondroblastoma, however, may also present with atypical features, such as prominent hemosiderin deposition, numerous giant cells, or the presence of a large aneurysmal bone cyst component. Malignant entities such as clear cell chondrosarcoma and chondroblastic osteosarcoma must also be considered. Recently, immunohistochemical stains such as DOG1 and SOX9 have been described in chondroblastoma, and K36M mutations in either the H3F3A or H3F3B genes have also been identified. While generally regarded as a benign entity, chondroblastoma manifests an intermediate type of behavior, given its ability to recur locally, and rarely, metastasize.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28557595     DOI: 10.5858/arpa.2016-0281-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  15 in total

1.  Missed radiographic and clinical findings in a case of non-idiopathic scoliosis resulting from chondroblastoma.

Authors:  Navraj S Sagoo; Edward P Southern; Andrew G King; Matthew W Stark; Lori A McBride
Journal:  Spine Deform       Date:  2020-08-21

Review 2.  Histone variants: The unsung guardians of the genome.

Authors:  Ernest O N Phillips; Akash Gunjan
Journal:  DNA Repair (Amst)       Date:  2022-02-17

3.  Primary maxillary chondrosarcoma: A case report.

Authors:  Juan Carlos Cuevas-González; Jesús Oscar Reyes-Escalera; José Luis González; Celeste Sánchez-Romero; León Francisco Espinosa-Cristóbal; Simón Yobanny Reyes-López; Karla Lizette Tovar Carrillo; Alejandro Donohue Cornejo
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

4.  A histone H3.3K36M mutation in mice causes an imbalance of histone modifications and defects in chondrocyte differentiation.

Authors:  Shusaku Abe; Hiroaki Nagatomo; Hiroyuki Sasaki; Takashi Ishiuchi
Journal:  Epigenetics       Date:  2020-11-16       Impact factor: 4.528

Review 5.  Chondroblastoma of the patella with secondary aneurysmal bone cyst, an easily misdiagnosed bone tumor:a case report with literature review.

Authors:  Jianping Zheng; Ningkui Niu; Jiandang Shi; Xu Zhang; Xi Zhu; Jiali Wang; Changhao Liu
Journal:  BMC Musculoskelet Disord       Date:  2021-04-23       Impact factor: 2.362

6.  Have the difficulties and complications of surgical treatment for chondroblastoma of the adjoining knee joint been overestimated?

Authors:  Qing Liu; Hongbo He; Yuhao Yuan; Hao Zeng; Feng Long; Jian Tian; Wei Luo
Journal:  J Bone Oncol       Date:  2019-05-13       Impact factor: 4.072

7.  Bone Tumours of the Talus: 18-Year Cohort of Patients With Rare Osteoid Lesions.

Authors:  Luke F Western; Rohit Dhawan; Gillian Cribb; Karen Shepherd; Paul Cool
Journal:  Cureus       Date:  2021-02-26

Review 8.  [Foot and ankle tumours : Part I: overview of incidence, diagnosis and staging of pedal tumours].

Authors:  T Grieser
Journal:  Radiologe       Date:  2018-05       Impact factor: 0.635

9.  Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis.

Authors:  Yajuan J Liu; Wenjing Wang; Jeffrey Yeh; Yu Wu; Jose G Mantilla; Christopher D M Fletcher; Robert W Ricciotti; Eleanor Y Chen
Journal:  Mod Pathol       Date:  2021-03-16       Impact factor: 7.842

10.  Chondroblastoma of the patella with pathological fracture in an adolescent: a case report.

Authors:  Yun Lang; Qing Yu; Yuehong Liu; Lejin Yang
Journal:  World J Surg Oncol       Date:  2019-12-12       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.